Literature DB >> 31099931

Fluorine-Containing Drugs Approved by the FDA in 2018.

Haibo Mei1, Jianlin Han1, Santos Fustero2,3, Mercedes Medio-Simon2,3, Daniel M Sedgwick2,3, Claudio Santi4, Renzo Ruzziconi5, Vadim A Soloshonok6,7.   

Abstract

Over the last two decades, fluorine substitution has become one of the essential structural traits in modern pharmaceuticals. Thus, about half of the most successful drugs (blockbuster drugs) contain fluorine atoms. In this review, we profile 17 fluorine-containing drugs approved by the food and drug administration (FDA) in 2018. The newly approved pharmaceuticals feature several types of aromatic F and CF3 , as well as aliphatic (CF2 ) substitution, offering advances in the treatment of various diseases, including cancer, HIV, malarial and smallpox infections.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIV; biochemistry; cancer; fluorine; substitution reactions

Mesh:

Substances:

Year:  2019        PMID: 31099931     DOI: 10.1002/chem.201901840

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  44 in total

1.  Development of chiral fluorinated alkyl derivatives of emixustat as drug candidates for the treatment of retinal degenerative diseases.

Authors:  Eliav Blum; Jianye Zhang; Edward Korshin; Krzysztof Palczewski; Arie Gruzman
Journal:  Bioorg Med Chem Lett       Date:  2020-07-18       Impact factor: 2.823

2.  Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance.

Authors:  Jacqueto Zephyr; Desaboini Nageswara Rao; Sang V Vo; Mina Henes; Klajdi Kosovrasti; Ashley N Matthew; Adam K Hedger; Jennifer Timm; Elise T Chan; Akbar Ali; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Mol Biol       Date:  2022-02-17       Impact factor: 6.151

3.  The precious fluorine on the ring: fluorine NMR for biological systems.

Authors:  Andras Boeszoermenyi; Barbara Ogórek; Akshay Jain; Haribabu Arthanari; Gerhard Wagner
Journal:  J Biomol NMR       Date:  2020-07-10       Impact factor: 2.835

Review 4.  Catalytic stereoselective Mannich-type reactions for construction of fluorinated compounds.

Authors:  Minoo Dabiri; Noushin Farajinia Lehi; Reza Mohammadian
Journal:  Mol Divers       Date:  2021-07-06       Impact factor: 2.943

5.  Oligomerization engineering of the fluorinase enzyme leads to an active trimer that supports synthesis of fluorometabolites in vitro.

Authors:  Tiia Kittilä; Patricia Calero; Folmer Fredslund; Phillip T Lowe; David Tezé; Manuel Nieto-Domínguez; David O'Hagan; Pablo I Nikel; Ditte H Welner
Journal:  Microb Biotechnol       Date:  2022-01-27       Impact factor: 6.575

6.  Photocatalytic trifluoromethoxylation of arenes and heteroarenes in continuous-flow.

Authors:  Alexander V Nyuchev; Ting Wan; Borja Cendón; Carlo Sambiagio; Job J C Struijs; Michelle Ho; Moisés Gulías; Ying Wang; Timothy Noël
Journal:  Beilstein J Org Chem       Date:  2020-06-15       Impact factor: 2.883

Review 7.  Perfluorocarbons in Chemical Biology.

Authors:  Margeaux A Miller; Ellen M Sletten
Journal:  Chembiochem       Date:  2020-08-05       Impact factor: 3.164

Review 8.  Chemical Aspects of Human and Environmental Overload with Fluorine.

Authors:  Jianlin Han; Loránd Kiss; Haibo Mei; Attila Márió Remete; Maja Ponikvar-Svet; Daniel Mark Sedgwick; Raquel Roman; Santos Fustero; Hiroki Moriwaki; Vadim A Soloshonok
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

Review 9.  Recommended Tests for the Self-Disproportionation of Enantiomers (SDE) to Ensure Accurate Reporting of the Stereochemical Outcome of Enantioselective Reactions.

Authors:  Jianlin Han; Alicja Wzorek; Karel D Klika; Vadim A Soloshonok
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

10.  Defluorodearomatization: A Photocatalytic Birch-Like Reduction That Enables C-C Bond Formation and Provides Access to Unnatural Cannabinoids.

Authors:  Jon I Day; Sascha Grotjahn; Sameera Senaweera; Burkhard Koenig; Jimmie D Weaver Iii
Journal:  J Org Chem       Date:  2021-06-02       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.